Similarly, participants in the top, compared with bottom third of IL-6 at baseline had higher depression severity score at follow-up (adjusted β = 0.43; 95% C.I., 0.01–1.15; p = 0.049) (Supplementary Table 4). Here, IL6 is linked to depressive symptom measurement.